# Ketamine for Depression and Alcohol Dependence

> **NCT01551329** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 5 (actual)

## Conditions studied

- Depression
- Alcohol Dependence

## Interventions

- **DRUG:** Ketalar (ketamine)

## Key facts

- **NCT ID:** NCT01551329
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551329, "Ketamine for Depression and Alcohol Dependence". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01551329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*